Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

NCT06870539 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06870539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06870539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
March 7, 2025
Completion date
July 31, 2025
Enrollment
49 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related cognitive dysfunction, cytomegaloviral infection, fallopian tube carcinoma, ovarian carcinoma, primary peritoneal carcinoma